Covington Fights Doc Request In Prograf Antitrust Row

Law360, New York (June 19, 2013, 2:08 PM EDT) -- Covington & Burling LLP said Tuesday that certain evidence requested in Massachusetts federal court by a class of direct purchasers is not relevant to multidistrict antitrust litigation accusing Astellas Pharma US Inc. of delaying entry of a generic version of the immunosuppressant Prograf.

Fighting a motion to compel lodged by retail pharmacies and other direct purchasers of Prograf, Covington argued that the purchasers sought discovery that would place an unnecessary burden on the firm and went beyond the scope of the MDL, according to the firm's...
To view the full article, register now.